ResearchBib Share Your Research, Maximize Your Social Impacts
Sign for Notice Everyday Sign up >> Login

Overview: Does the FDA call in advance or just sho 2012 - The FDA Inspection Process: From SOP to 483 - Webinar By GlobalCompliancePanel

Date2012-07-19

Deadline2012-07-19

VenueWilmington, USA - United States USA - United States

KeywordsFDA Inspection Process,SOP to 483,FDA inspection,FDA guidance documents,Regulatory Management

Websitehttp://alturl.com/85vs4

Topics/Call fo Papers

Overview: Does the FDA call in advance or just show up at my door? Where do I let the inspector go? Do I give them a tour? What should I let them see? Who should I let them talk to? Are they ever going to leave? The FDA inspection is the most nerve-wracking event in the life of a regulatory professional - you're in charge of compliance, usually in the background, and NOW you're in the spotlight, and if your performance isn't good, it's not the show that may close, it's YOUR COMPANY! However, adequate planning, training, composure, and understanding should result in many encore presentations!
This session will discuss how to prepare for the inspection, what to do during the inspection and the close-out interview, and how to respond to the inspection. Also contained in this session will be the limits of FDA's scope during an inspection, including what documents you are not required to show them, and the permissibility of photographs and affidavits.
Areas Covered in the Session:
How to prepare for an FDA inspection
Development and contents of an SOP for FDA inspection
Personnel training before inspection
Proper behavior during an inspection
Limitations of scope of inspection
Response to investigation findings
FDA guidance documents used by their inspectors
Who Will Benefit: This webinar will provide valuable assistance to all companies that market in the U.S., since they are by definition subject to FDA regulation, in the Medical Device, Diagnostic, Pharmaceutical, and Biologics fields. The employees who will benefit include:
Executive/Senior Management
Regulatory Management
QA Management
Any personnel who may have direct interaction with FDA officials
Quality System Auditors
Consultants
Jeff Kasoff, RAC, is the Director of Quality at Byrne Medical, a leading manufacturer of endoscopy and colonoscopy devices, where he oversees the operation of the quality system. In this position, Jeff is responsible for oversight of the document control system, including maintenance of regulatory documentation. Prior to this, Jeff spent 13 years at Life-Tech, Inc. as the Director of Regulatory Affairs, where he was responsible for compliance of the corporate quality system. Jeff received his regulatory affairs certification in 1996.
Price List:
Live : $245.00
Corporate live : $495.00
Recorded : $295.00
Phone: 800-447-9407
Fax: 302-288-6884
webinars-AT-globalcompliancepanel.com
http://www.globalcompliancepanel.com
http://alturl.com/85vs4

Last modified: 2012-06-28 13:25:07